Related Experiment Video
Updated: Aug 25, 2025

A Porcine Heterotopic Heart Transplantation Protocol for Delivery of Therapeutics to a Cardiac Allograft
Published on: February 14, 2022
Cannabis Use and Heart Transplantation: Disparities and Opportunities to Improve Outcomes
Onyedika J Ilonze1, Denise C Vidot2, Khadijah Breathett1
1Division of Cardiovascular Medicine, Krannert Cardiovascular Research Center, Indiana University, Indianapolis (O.J.I., K.B., S.V.R.).
Insights
Cannabis use in advanced heart failure patients may worsen disparities in heart transplantation (HT) access. Standardized evaluation is needed to ensure equitable organ allocation for these individuals.
Area of Science:
- Cardiology
- Transplantation Medicine
- Substance Use Research
Background:
- Heart transplantation (HT) is the leading therapy for advanced heart failure.
- Historically, substance abuse has disqualified patients from HT.
- Increasing cannabis acceptance and use complicate HT candidacy evaluations.
Purpose of the Study:
- To review pre- and post-HT considerations for cannabis use.
- To provide context on attitudes toward cannabis versus opiates in HT.
- To identify research gaps for a standardized cannabis evaluation process in HT.
Main Methods:
- Literature review of pre-HT and post-HT considerations.
- Comparative analysis of attitudes towards cannabis and opiates.
- Identification of unmet research needs.
Main Results:
- Cannabis use evaluation lacks standardization, potentially worsening disparities.
- Historical contraindications for substance abuse are challenged by cannabis decriminalization.
- Attitudes towards cannabis use in HT candidates differ from opiates.
Conclusions:
- Standardized evaluation for cannabis use in HT candidates is critical.
- Addressing clinician biases and regional disparities is necessary for equitable HT listing.
- Further research is required to inform evidence-based guidelines for cannabis use in HT.
Abstract:
Heart transplantation (HT) remains the optimal therapy for many patients with advanced heart failure. Use of substances of potential abuse has historically been a contraindication to HT. Decriminalization of cannabis, increasing cannabis use, clinician biases, and lack of consensus for evaluating patients with heart failure who use cannabis all have the potential to exacerbate racial and ethnic and regional disparities in HT listing and organ allocation. Here' we review pertinent pre-HT and post-HT considerations related to cannabis use' and relative attitudes between opiates and cannabis are offered for context. We conclude with identifying unmet research needs pertaining to the use of cannabis in HT that can inform a standardized evaluation process.
More Related Videos
Related Concept Videos
Kidney Transplant I: Introduction
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Cardiomyopathy V: Interprofessional Care
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...

